Close Menu
    Latest Posts

    Inflation Continues to Challenge U.S. Economy

    November 10, 2026

    Corporate America is making a trillion-dollar mistake about retirement

    November 10, 2026

    Anthropic officially sets the stage for an IPO valuing the company north of $1 trillion

    November 10, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Inflation Continues to Challenge U.S. Economy
    • Corporate America is making a trillion-dollar mistake about retirement
    • Anthropic officially sets the stage for an IPO valuing the company north of $1 trillion
    • 2027 will be an ‘inflection year’ as R2, autonomy ramp up
    • Cash, Debt, and Corporate Investment
    • Goldman Sachs, Citi among banks said to commit $270 million to stablecoin venture
    • Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?
    • AI financing remains strong despite market jitters
    Facebook X (Twitter) Instagram
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Wednesday, November 11
    • Home
    • Banking
    • Business
    • Crypto
    • Economy
    • Fintech
    • Investing
    • Markets
    • Stocks
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Home»Economy»Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
    Economy

    Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

    AdminBy AdminJune 8, 2026No Comments1 Min Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
    Share
    Facebook Twitter Pinterest Email Copy Link


    On this episode of Stock Movers with Alexis Christoforous:

    – Shares of The Campbell’s Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate.
    – Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company’s incretin portfolio is “not built around singular blockbusters.”
    – Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell’s in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement. (Source: Bloomberg)

    Beat Campbell039s drug earnings Eli Lilly Movers obesity Results Stock
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    Admin
    • Website

    Related Posts

    Economy

    Inflation Continues to Challenge U.S. Economy

    November 10, 2026
    Stocks

    Berkshire Hathaway (BRK.A) earnings Q3 2026

    November 9, 2026
    Economy

    OpenAI safety leader quits, warning AI company’s culture is ‘broken’ | OpenAI

    October 4, 2026
    Investing

    Wall Street braces for two wildly different results in Brazil election

    October 3, 2026
    Fintech

    Stocks to buy now, ahead of their earnings, according to Goldman Sachs

    October 3, 2026
    Economy

    The Fed – Bells and Whistles of Nowcasting Models: Which Matter and When?

    October 3, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Inflation Continues to Challenge U.S. Economy

    November 10, 2026

    Corporate America is making a trillion-dollar mistake about retirement

    November 10, 2026

    Anthropic officially sets the stage for an IPO valuing the company north of $1 trillion

    November 10, 2026

    2027 will be an ‘inflection year’ as R2, autonomy ramp up

    November 10, 2026
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    About Us

    Welcome to MoneyLister.com — your trusted source for reliable insights in the world of finance, investing, and digital assets.

    At MoneyLister, our mission is simple: to make complex financial topics easy to understand and accessible to everyone. Whether you're a beginner exploring cryptocurrency, an investor tracking the stock market, or a professional staying updated on global business trends, we provide clear, informative, and up-to-date content to help you stay ahead.

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    Inflation Continues to Challenge U.S. Economy

    November 10, 2026

    Corporate America is making a trillion-dollar mistake about retirement

    November 10, 2026

    Anthropic officially sets the stage for an IPO valuing the company north of $1 trillion

    November 10, 2026
    Recent Posts
    • Inflation Continues to Challenge U.S. Economy
    • Corporate America is making a trillion-dollar mistake about retirement
    • Anthropic officially sets the stage for an IPO valuing the company north of $1 trillion
    • 2027 will be an ‘inflection year’ as R2, autonomy ramp up
    • Cash, Debt, and Corporate Investment
    © 2026 moneylister. Designed by Pro.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.